Latest news with #cognitiveEnhancement
Associated Press
23-05-2025
- Business
- Associated Press
U.S. Nootropics Market Trends Analysis and Growth Forecasts, 2025-2030 - Workplace and Academic Pressures Propel Consumer Shift Toward Cognitive Supplements
DUBLIN--(BUSINESS WIRE)--May 23, 2025-- The 'U.S. Nootropics Market Size, Share & Trends Analysis Report by Product (Natural, Synthetic), Form (Powder, Drinks, Gummies), Application, Distribution Channel, with Growth Forecasts, 2025-2030" report has been added to offering. The U.S. Nootropics Market was valued at USD 2.81 Billion in 2024, and is projected to reach USD 4.68 Billion by 2030, rising at a CAGR of 9.00% This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base. Natural products held a major share in 2024. This is due to consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of 'natural' with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness philosophies. The drinks segment held the largest share in 2024. This can be attributed to their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate into daily routines, offering an easily consumable format compared to capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format also allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal to a wider consumer base. Cognitive enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers to competitive academic pursuits. Individuals are actively seeking solutions to improve focus, memory, attention span, and learning capabilities to gain a competitive edge and enhance productivity. Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market. U.S. Nootropics Market Report Highlights Why Should You Buy This Report? Companies Featured Key Attributes: Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Product Outlook 2.3. Form Outlook 2.4. Application Outlook 2.5. Distribution Channel Outlook Chapter 3. U.S. Nootropics Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.2. Industry Value Chain Analysis 3.2.1. Raw Material Outlook 3.2.2. Manufacturing & Technology Outlook 3.2.3. Profit Margin Analysis 3.3. Market Dynamics 3.3.1. Market Driver Analysis 3.3.2. Market Restraint Analysis 3.3.3. Market Opportunities 3.3.4. Market Challenges 3.4. Industry Analysis - Porter's Five Forces Analysis 3.5. Market Entry Strategies Chapter 4. U.S. Nootropics Market: Product Estimates & Trend Analysis 4.1. U.S. Nootropics Market, by Product: Key Takeaways 4.2. Product Movement Analysis & Market Share, 2024 & 2030 4.3. Market Estimates & Forecasts, by Product, 2018-2030 (USD Million) 4.3.1. Natural 4.3.1.1. Market estimates and forecast, 2018-2030 (USD Million) 4.3.2. Synthetic 4.3.2.1. Market estimates and forecast, 2018-2030 (USD Million) Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis 5.1. U.S. Nootropics Market, by Form: Key Takeaways 5.2. Form Movement Analysis & Market Share, 2024 & 2030 5.3. Market Estimates & Forecasts, by Form, 2018-2030 (USD Million) 5.3.1. Capsules/Tablets 5.3.2. Powder 5.3.3. Drinks 5.3.4. Gummies 5.3.5. Others (Liquid, patches, and novel delivery methods) Chapter 6. U.S. Nootropics Market: Application Estimates & Trend Analysis 6.1. U.S. Nootropics Market, by Application: Key Takeaways 6.2. Application Movement Analysis & Market Share, 2024 & 2030 6.3. Market Estimates & Forecasts, by Application, 2018-2030 (USD Million) 6.3.1. Cognitive Enhance 6.3.2. Mood & Stress Management 6.3.3. Sleep Optimization 6.3.4. Energy & Physical Performance 6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting) Chapter 7. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis 7.1. U.S. Nootropics Market, by Distribution Channel: Key Takeaways 7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030 7.3. Market Estimates & Forecasts, by Form, 2018-2030 (USD Million) 7.3.1. Offline 7.3.2. Online Chapter 8. Competitive Analysis 8.1. Recent developments & impact analysis, by key market participants 8.2. Company Categorization 8.3. Participant's Overview 8.4. Financial Performance 8.5. Product Benchmarking 8.6. Company Market Share Analysis, 2024 (%) 8.7. Company Heat Map Analysis 8.8. Strategy Mapping 8.9. Company Profiles 8.9.1. Company Overview 8.9.2. Financial Performance 8.9.3. Product Portfolios 8.9.4. Strategic Initiatives For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: FITNESS & NUTRITION HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 05/23/2025 09:26 AM/DISC: 05/23/2025 09:25 AM
Yahoo
22-05-2025
- Business
- Yahoo
U.S. $4.68 Bn Nootropics Market Growth Forecasts to 2030: Expanding Use Cases Push Nootropics Beyond Brain Boosting to Stress and Mood Support
Robust expansion is fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base. U.S. Nootropics Market Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "U.S. Nootropics Market Size, Share & Trends Analysis Report by Product (Natural, Synthetic), Form (Powder, Drinks, Gummies), Application, Distribution Channel, with Growth Forecasts, 2025-2030" report has been added to U.S. Nootropics Market was valued at USD 2.81 Billion in 2024, and is projected to reach USD 4.68 Billion by 2030, rising at a CAGR of 9.00% This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base. Natural products held a major share in 2024. This is due to consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of "natural" with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness drinks segment held the largest share in can be attributed to their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate into daily routines, offering an easily consumable format compared to capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format also allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal to a wider consumer enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers to competitive academic pursuits. Individuals are actively seeking solutions to improve focus, memory, attention span, and learning capabilities to gain a competitive edge and enhance market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market.U.S. Nootropics Market Report Highlights Based on product, the synthetic segment is estimated to grow at a substantial CAGR over the forecast period. The capacity for targeted cognitive enhancement and precise formulations have stimulated the growth. Ongoing research enables the development of novel synthetic compounds with specific mechanisms of action and enhanced potency compared to natural extracts. Synthetic production allows for greater control over purity and consistency, potentially leading to more predictable and reliable effects, appealing to users seeking optimized and tailored cognitive benefits. Based on form, the gummies segment is anticipated to grow at a significant CAGR over the forecast period, driven by the appealing and convenient format of gummies. Gummies offer a palatable and enjoyable consumption experience, masking the potential bitterness of ingredients and resembling popular confectionery. Based on application, the sleep optimization segment is anticipated to grow at a faster CAGR over the forecast period. The increasing recognition of sleep's crucial role in cognitive function and overall well-being and rising rates of sleep disorders and stress-induced sleep issues are driving demand for natural sleep aids. Based on distribution channel, the online segment is anticipated to grow at a faster CAGR over the forecast period due to enhanced accessibility and convenience. They offer a wider selection of nootropics compared to brick-and-mortar stores, often at competitive prices due to reduced overhead. Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Companies Featured Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC) Unilever Onnit Labs, Inc. Amway GNC Holdings, LLC NeuroGum, Inc. Qualia Life Sciences, LLC NOW Foods. Performance Lab USA Corp. Natural Stacks BrainMD Health Nootropics Depot Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $2.81 Billion Forecasted Market Value (USD) by 2030 $4.68 Billion Compound Annual Growth Rate 9.0% Regions Covered United States Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Product Outlook2.3. Form Outlook2.4. Application Outlook2.5. Distribution Channel OutlookChapter 3. U.S. Nootropics Market Variables, Trends & Scope3.1. Market Lineage Outlook3.2. Industry Value Chain Analysis3.2.1. Raw Material Outlook3.2.2. Manufacturing & Technology Outlook3.2.3. Profit Margin Analysis3.3. Market Dynamics3.3.1. Market Driver Analysis3.3.2. Market Restraint Analysis3.3.3. Market Opportunities3.3.4. Market Challenges3.4. Industry Analysis - Porter's Five Forces Analysis3.5. Market Entry StrategiesChapter 4. U.S. Nootropics Market: Product Estimates & Trend Analysis4.1. U.S. Nootropics Market, by Product: Key Takeaways4.2. Product Movement Analysis & Market Share, 2024 & 20304.3. Market Estimates & Forecasts, by Product, 2018-2030 (USD Million)4.3.1. Natural4.3.1.1. Market estimates and forecast, 2018-2030 (USD Million)4.3.2. Synthetic4.3.2.1. Market estimates and forecast, 2018-2030 (USD Million)Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis5.1. U.S. Nootropics Market, by Form: Key Takeaways5.2. Form Movement Analysis & Market Share, 2024 & 20305.3. Market Estimates & Forecasts, by Form, 2018-2030 (USD Million)5.3.1. Capsules/Tablets5.3.2. Powder5.3.3. Drinks5.3.4. Gummies5.3.5. Others (Liquid, patches, and novel delivery methods)Chapter 6. U.S. Nootropics Market: Application Estimates & Trend Analysis6.1. U.S. Nootropics Market, by Application: Key Takeaways6.2. Application Movement Analysis & Market Share, 2024 & 20306.3. Market Estimates & Forecasts, by Application, 2018-2030 (USD Million)6.3.1. Cognitive Enhance6.3.2. Mood & Stress Management6.3.3. Sleep Optimization6.3.4. Energy & Physical Performance6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting)Chapter 7. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis7.1. U.S. Nootropics Market, by Distribution Channel: Key Takeaways7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 20307.3. Market Estimates & Forecasts, by Form, 2018-2030 (USD Million)7.3.1. Offline7.3.2. OnlineChapter 8. Competitive Analysis8.1. Recent developments & impact analysis, by key market participants8.2. Company Categorization8.3. Participant's Overview8.4. Financial Performance8.5. Product Benchmarking8.6. Company Market Share Analysis, 2024 (%)8.7. Company Heat Map Analysis8.8. Strategy Mapping8.9. Company Profiles8.9.1. Company Overview8.9.2. Financial Performance8.9.3. Product Portfolios8.9.4. Strategic InitiativesFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Nootropics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
